Tapeworm infestation of human brai

Phase 4

• Conditions: Health Condition 1: - Health Condition 2: - Health Condition 3: B998- Other infectious disease

• Registration Number: CTRI/2021/12/038492
• Lead Sponsor: Virender Gehlawat

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Children aged 1- 14 years with multiple neurocysticercosis will be enrolled satisfying following criteria

1.Conclusive demonstration of scolex within a cystic lesion on neuroimaging studies.

2.cystic lesion without a discernible scolex

3.Enhancing lesions.

4.Multilobulated cystic lesions in the subarachnoid space

Exclusion Criteria

1.Children with single lesion and more than five lesions at diagnosis.

2.Children with extraparenchymal lesions including intraocular and intraventricular NCC.

3. Children with encephalopathy and signs of raised intracranial pressure.

4.Chidren who have recieved antiparasitic drugs in preceding 3 months.

5.Children with intellectual disability or global developmental delay, coexisting neurodegenerative/ neurometabolic or any other structural pathology.

6.Children with recognised progressive neurological illness.

7. Children with renal, pulmonary, cardiac or hepatic dysfunction.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of children with complete resolution of all viable and non calcified cysts at six monthsTimepoint: six months

Secondary Outcome Measures

Name	Time	Method
Adverse effectsTimepoint: 6 months;Calcification of cystTimepoint: 6 months;Seizure recurrenceTimepoint: 6 months